Cardiac Arrest Clinical Trial
Official title:
NSE Ancillary Study of The Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.
Cardiac arrest is at present a major cause of mortality as well as a cause of disability for
the surviving victims.In Europe, every year counts as 300,000 cardiac arrests responsible for
250,000 deaths. Thus, less than 20 % of patients discharged home with impaired quality of
life associated with symptoms of tiredness, stress, anxiety. The prognosis is related to the
initial cardiac rhythm present during the initiation of resuscitation. Recent progress in the
improvement of mortality and neurological outcome has been achieved over the last decade
thanks to the systematic implementation of a period of targeted temperature control between
32 and 34 ° C in patients who benefited from the realization of at least one electrical
external shock.
There are theoretical and clinical arguments to think that achieving the same way a period of
targeted temperature control between 32 and 34 ° C in patients treated for cardiac arrest
with a non- shockable rhythm on arrival can also benefit from this procedure. However other
arguments are against this hypothesis including an increase in the risk of infection ,
worsening of the patient's hemodynamic status with no benefit to him. To answer this
question, we conduce a randomized multicenter study testing the potential improvement of
neurological outcome through this procedure targeted temperature control between 32.5 and
33.5 ° C in these patients.
NSE-Ancillary Study of HYPERION Trial will determine impact on neurospecific enolase (brain
biomarker) of two temperature target for targeted temperature management (33°C or 37°C) after
cardiac arrest in non-shockable rhythm.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06048068 -
Removing Surrogates' Uncertainty to Reduce Fear and Anxiety After Cardiac Events
|
N/A | |
Recruiting |
NCT05558228 -
Accuracy of Doppler Ultrasound Versus Manual Palpation of Pulse in Cardiac Arrest
|
||
Completed |
NCT03685383 -
Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation
|
N/A | |
Completed |
NCT04619498 -
Effectiveness of an Interactive Cognitive Support Tablet App to Improve the Management of Pediatric Cardiac Arrest
|
N/A | |
Completed |
NCT04584645 -
A Digital Flu Intervention for People With Cardiovascular Conditions
|
N/A | |
Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
Withdrawn |
NCT02352350 -
Lactate in Cardiac Arrest
|
N/A | |
Completed |
NCT03024021 -
Cerebral Oxymetry and Neurological Outcome in Therapeutic Hypothermia
|
||
Completed |
NCT02247947 -
Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome
|
||
Completed |
NCT02275234 -
Care After Resuscitation
|
||
Completed |
NCT01944605 -
Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest
|
N/A | |
Completed |
NCT01972087 -
Simulation Training to Improve 911 Dispatcher Identification of Cardiac Arrest
|
N/A | |
Completed |
NCT01936597 -
Prospective Study of 3 Phone Assistance Strategies to Achieve a Continuous Cardiac Massage
|
N/A | |
Active, not recruiting |
NCT01239420 -
Norwegian Cardio-Respiratory Arrest Study
|
||
Completed |
NCT00880087 -
Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-IH [In Hospital] Trial
|
N/A | |
Completed |
NCT01191736 -
Ultra-Brief Versus Brief Hands Only CPR Video Training With and Without Psychomotor Skill Practice
|
N/A | |
Completed |
NCT00878644 -
Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-OH [Out of Hospital] Trial
|
Phase 3 | |
Completed |
NCT00729794 -
Vasopressin, Epinephrine, and Steroids for Cardiac Arrest
|
Phase 3 | |
Recruiting |
NCT00441753 -
Cerebral Bloodflow and Carbondioxide Reactivity During Mild Therapeutic Hypothermia in Patients After Cardiac Arrest
|
N/A | |
Completed |
NCT00347477 -
Fluid Shifts in Patients Treated With Therapeutic Hypothermia After Cardiac Arrest
|
Phase 3 |